Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ptc Therapeutics (PTCT)

Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ptc Therapeutics 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 USA

www.ptcbio.com Employees: 995 P: 908-222-7000 F: 908-222-7231

Description:

PTC Therapeutics, Inc. is a biopharmaceutical company. It is focused on the discovery and development of orally administered, small-molecule drugs for genetic disorders, oncology and infectious disease. PTC Therapeutics, Inc. is based in South Plainfield, United States.

Key Statistics

Overview:

Market Capitalization, $K 3,106,960
Enterprise Value, $K 4,611,270
Shares Outstanding, K 76,924
Annual Sales, $ 937,820 K
Annual Net Income, $ -626,600 K
Last Quarter Sales, $ 186,700 K
Last Quarter Net Income, $ -99,180 K
EBIT, $ -7,800 K
EBITDA, $ 446,260 K
60-Month Beta 0.63
% of Insider Shareholders 5.50%
Float, K 72,693
% Float 94.50%
Short Volume Ratio 0.21

Growth:

1-Year Return 108.19%
3-Year Return 2.25%
5-Year Return -7.55%
5-Year Revenue Growth 254.26%
5-Year Earnings Growth -96.74%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.16 on 08/08/24
Next Earnings Date 11/07/24 [AMC]
Earnings Per Share ttm -4.36
EPS Growth vs. Prev Qtr 3.33%
EPS Growth vs. Prev Year 56.39%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PTCT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -19.37%
Profit Margin % -66.81%
Debt/Equity -2.42
Price/Sales 3.32
Price/Cash Flow 16.70
Price/Book N/A
Book Value/Share -12.78
Interest Coverage -4.39
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar